0001161697-22-000121.txt : 20220216
0001161697-22-000121.hdr.sgml : 20220216
20220216170524
ACCESSION NUMBER: 0001161697-22-000121
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220214
FILED AS OF DATE: 20220216
DATE AS OF CHANGE: 20220216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sundaram Preethi
CENTRAL INDEX KEY: 0001872422
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 22644536
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form_4.xml
FORM 4 FOR 02-14-2022
X0306
4
2022-02-14
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001872422
Sundaram Preethi
355 ALHAMBRA CIRCLE
SUITE 801
CORAL GABLES
FL
33134
0
1
0
0
Chief Strategy Officer
Restricted Stock Units
2022-02-14
4
A
0
50000
0
A
Common Stock
50000
417500
D
Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
Derivative securities vest in equal tranches, 1/3rd on February 14, 2023, 1/3rd on February 14, 2024 and 1/3rd on February 14, 2025.
Shares of common stock will be delivered to the Reporting Person within sixty (60) days of vesting.
/s/ Preethi Sundaram
2022-02-16